Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Capital Expenditures: 2018-2021

Historic Capital Expenditures for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2021 value amounting to $45,000.

  • ENDRA Life Sciences' Capital Expenditures rose 101.34% to $45,000 in Q1 2021 from the same period last year, while for Mar 2021 it was $120,333, marking a year-over-year increase of 82.47%. This contributed to the annual value of $16,000 for FY2024, which is 52.78% down from last year.
  • Per ENDRA Life Sciences' latest filing, its Capital Expenditures stood at $45,000 for Q1 2021, which was down 30.61% from $64,850 recorded in Q4 2020.
  • ENDRA Life Sciences' 5-year Capital Expenditures high stood at $100,000 for Q3 2018, and its period low was -$11,867 during Q3 2020.
  • In the last 3 years, ENDRA Life Sciences' Capital Expenditures had a median value of $22,350 in 2020 and averaged $23,418.
  • Data for ENDRA Life Sciences' Capital Expenditures shows a peak YoY spiked of 326.61% (in 2020) over the last 5 years.
  • Over the past 4 years, ENDRA Life Sciences' Capital Expenditures (Quarterly) stood at $100,000 in 2018, then reached $38,357 in 2019, then skyrocketed by 69.07% to $64,850 in 2020, then skyrocketed by 101.34% to $45,000 in 2021.
  • Its last three reported values are $45,000 in Q1 2021, $64,850 for Q4 2020, and -$11,867 during Q3 2020.